| C-STRIDE China n = 3168 | ROUTE Japan n = 1138 | CRIC US n = 3612 | CRISIS UK n = 1325 | MERENA Spain n = 1129 |
---|---|---|---|---|---|
Inclusion range of eGFR (ml/min/1.73 m2) | 15–90 | 0–90 | 20–70 | 10–60 | 15–60 |
Age (years) | 48.2 | 68 | 58.2 | 65.1 | 68 |
Male gender (%) | 59.2 | 69.6 | 54 | 63.7 | 64 |
BMI (kg/m2) | 24.5 | 23 | 32.1 | Â | 28.4 |
Actual eGFR (ml/min/1.73Â m2) | 50.7 | 32.7 | 43.4 | 30.9 | 28 |
Diabetes (%) | 21.7 | 37.1 | 47 | 32.4 | 40.8 |
Hypertension (%) | 66.5 | 90.2 | 86 | Â | 92.7 |
 SBP (mmHg) | 129.3 | 140 | 127.7 | 138.3 | 141 |
 DBP (mmHg) | 80.9 | 78 | 71.4 | 75.2 | 76 |
Hb (g/dl) | 12.76 | 11.9 | 12.7 | 12.41 | 12.8 |
HDL-C (mg/dl) | 44.86 | Â | Â | Â | Â |
LDL-C (mg/dl) | 108.66 | 110 | 102.5 | Â | 116 |
Ca (mg/dl) | 8.9 | 9.1 | 9.2 | 9.14 | Â |
P (mg/dl) | 3.7 | 3.6 | 3.7 | 3.72 | 3.7 |
iPTH (pg/ml) | 63.6 | 109 | 53 | 93.2 | 145 |
Proteinuria (mean) | Â | 2.16Â g/24gCr | Â | 1.08Â g/24Â h | 1.2Â g/24Â h |
(median) | 0.94Â g/24Â h | 0.74Â g/gCr | 0.17Â g/24Â h | Â | Â |
CVD prevalence (%) | 9.8 | 26.8 | 33.44 | 47.2 | 39.1 |